Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Eylea 40mg/ml


Contraindicated
Embryotoxic and foetotoxic in animals

Contraindicated
Eylea 40mg/ml :
Type Medicine Authorised
Originator Biotech (Eylea)
Agent Droguerie R. Pharaon et Fils
Distributor Droguerie R. Pharaon et Fils
Laboratory Bayer
Responsible Party Bayer AG
Origin Germany
Manufacturer Bayer Pharma AG
Origin Germany
ATC S01LA05

Your comment will appear shortly after approval

Eylea 40mg/ml :

Revision Date : 24/02/2015


Effect Frequency
Abnormal sensation in eye Uncommon
Anterior chamber flare Uncommon
Blindness Uncommon
Cataract Common
Cataract cortical Common
Cataract nuclear Common
Cataract subcapsular Common
Cataract traumatic Rare
Cerebrovascular accident Not known
Conjunctival haemorrhage Very Common
Conjunctival hyperaemia (Conjunctival redness) (Conjunctival injection) Common
Corneal abrasion Common
Corneal epithelium defect Uncommon
Corneal erosion Common
Corneal oedema Common
Death Not known
Detachment of retinal pigment epithelium Common
Embolism arterial Not known
Endophthalmitis Uncommon
Eye pain Common
Eyelid irritation Uncommon
Eyelid oedema Common
Foreign body sensation in eyes Common
Hypersensitivity Uncommon
Hypopyon Rare
Injection site haemorrhage Common
Injection site irritation Uncommon
Injection site pain Common
Intraocular pressure increased Common
Iridocyclitis Uncommon
Iritis Uncommon
Lacrimation increased (Epiphora) Common
Lenticular opacities Uncommon
Myocardial infarction Not known
Ocular hyperaemia Common
Punctate keratitis Common
Retinal degeneration Common
Retinal detachment Uncommon
Retinal pigment epithelial tear Common
Retinal vascular thrombosis Uncommon
Uveitis Uncommon
Vision blurred Common
Visual acuity reduced Very Common
Vitreous detachment Common
Vitreous floaters Common
Vitreous haemorrhage Common
Vitritis Rare

Different Units By MoH Code

Revision Date : 01/03/2025

Eylea 40mg/ml  MoH 7420 :
Form Solution for injection
Packaging Bottle (Glass)
Package Size 1x100µl
Strength 40mg/ml
Storage Condition 2-8°C Protect from light. Do not freeze
Public Price 65161855.27 L.L.
Stratum E1
NSSF ✔
Quarantine ✘
Reg. Number 185991/13
Submission date 01/01/2013
Registration Year 2014


Price Comparison

● Country: Tunisia
● Package Size: 1x100µl
● Public Price: 9458 TND ( 273,005,170.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 9458 TND ( 273,005,170.00 LBP )
● Pricing Date: 04/02/2019
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1x0.1ml Glass Vial
● Public Price: 5434 AED ( 131,290,874.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Pharmacy Price: 4629.26 AED ( 111847550.86 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1x0.1ml Glass Vial
● Public Price: 5434 AED ( 131,290,874.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Pharmacy Price: 4629.26 AED ( 111847550.86 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 1
● Public Price: 1063.35 CHF ( 109,971,657.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1063,35 CHF ( 109,935,460.00 LBP )
● Exfactory Price: 913.48 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 1
● Public Price: 1102.23 EUR ( 106,779,633.48 LBP )
● Pack size unit used: 1
● Cost/Unit: 1102,23 EUR ( 106,757,352.00 LBP )
● Exfactory Price: 667.85 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 1
● Public Price: 4246 QAR ( 104,273,268.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 4246 QAR ( 104,273,268.00 LBP )
● Pharmacy Price: 3487.174890524 QAR ( 85638040.961488 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 1
● Public Price: 1073.01 EUR ( 103,948,916.76 LBP )
● Pack size unit used: 1
● Cost/Unit: 1073,01 EUR ( 103,947,948.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Germany
● Package Size: 1x100µl
● Public Price: 1071.43 EUR ( 103,795,852.68 LBP )
● Pack size unit used: 1
● Cost/Unit: 1071,43 EUR ( 103,754,196.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Oman
● Package Size: 1
● Public Price: 446.99 OMR ( 103,135,790.66 LBP )
● Pack size unit used: 1
● Cost/Unit: 446,99 OMR ( 102,907,364.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 1hgl
● Public Price: 158545 ISK ( 102,261,525.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 158545 ISK ( 102,261,525.00 LBP )
● Pharmacy Price: 122369 ISK ( 78928005 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: 1x100µl
● Public Price: 348.3 KWD ( 102,254,262.30 LBP )
● Pack size unit used: 1
● Cost/Unit: 348,3 KWD ( 102,166,188.00 LBP )
● Pharmacy Price: 294.25 KWD ( 86386209.25 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 1
● Public Price: 7621.75 DKK ( 98,899,828.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 7621,75 DKK ( 98,890,096.00 LBP )
● Pharmacy Price: 5661.64 DKK ( 73465440.64 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 1
● Public Price: 816 GBP ( 92,737,584.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 816 GBP ( 92,737,584.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 1
● Public Price: 732.62 JOD ( 91,739,409.02 LBP )
● Pack size unit used: 1
● Cost/Unit: 732,62 JOD ( 91,661,772.00 LBP )
● Pharmacy Price: 704.44 JOD ( 88210681.24 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 1
● Public Price: 377.33 BHD ( 89,704,170.22 LBP )
● Pack size unit used: 1
● Cost/Unit: 377,33 BHD ( 89,625,718.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 1ml
● Public Price: 3633.1 SAR ( 85,886,484.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 3633,1 SAR ( 85,884,120.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 1
● Public Price: 872.09 EUR ( 84,484,590.84 LBP )
● Pack size unit used: 1
● Cost/Unit: 872,09 EUR ( 84,475,872.00 LBP )
● Pharmacy Price: 865.09 EUR ( 83806458.84 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 1
● Public Price: 830.71 EUR ( 80,475,861.96 LBP )
● Pack size unit used: 1
● Cost/Unit: 830,71 EUR ( 80,407,080.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1x100 microlitros
● Public Price: 829.83 EUR ( 80,390,611.08 LBP )
● Pack size unit used: 1
● Cost/Unit: 829,83 EUR ( 80,310,204.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Norway
● Package Size: 1x0,1ml
● Public Price: 9276.8 NOK ( 75,179,187.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 9276,8 NOK ( 75,172,704.00 LBP )
● Pharmacy Price: 7212.12 NOK ( 58447020.48 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 716.36 EUR ( 69,398,091.36 LBP )
● Pack size unit used: 1
● Cost/Unit: 716,36 EUR ( 69,363,216.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 1x0,1ml
● Public Price: 18081.43 CZK ( 69,052,981.17 LBP )
● Pack size unit used: 1
● Cost/Unit: 18081,43 CZK ( 69,051,339.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x100µl
● Public Price: 65161855.27 LBP ( 65,161,855.27 LBP )
● Pack size unit used: 1
● Cost/Unit: 65161855,27 LBP ( 65,161,855.00 LBP )
● Pricing Date: 03/09/2026

● Country: Greece
● Package Size: 1
● Public Price: 671.46 EUR ( 65,048,358.96 LBP )
● Pack size unit used: 1
● Cost/Unit: 671,46 EUR ( 65,003,796.00 LBP )
● Exfactory Price: 577.86 EUR
● Pharmacy Price: 586.53 EUR ( 56820680.28 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 1
● Public Price: 641.09 EUR ( 62,106,234.84 LBP )
● Pack size unit used: 1
● Cost/Unit: 641,09 EUR ( 62,097,516.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 1
● Public Price: 2828.43 TRY ( 7,580,192.40 LBP )
● Pack size unit used: 1
● Cost/Unit: 2828,43 TRY ( 7,579,040.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Argentina
● Package Size: 1
● Public Price: 61418.55 ARS ( 5,896,180.80 LBP )
● Pack size unit used: 1
● Cost/Unit: 61418,55 ARS ( 5,896,128.00 LBP )
● Reference: Ministerio de Salud
● Pricing Date: 13/05/2019
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 1 inj
● Exfactory Price: 1250 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Portugal
● Package Size: 1
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Diabetic macular oedema :
● Cost/Unit: 9458 TND ( 273,005,170.00 LBP )
● Cost/Day: 9458 TND ( 273,005,170.00 LBP )
● Cost/Month: 9458 TND ( 273,005,170.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 9458 TND ( 273,005,170.00 LBP )
● Cost/Day: 9458 TND ( 273,005,170.00 LBP )
● Cost/Month: 9458 TND ( 273,005,170.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 9458 TND ( 273,005,170.00 LBP )
● Cost/Day: 9458 TND ( 273,005,170.00 LBP )
● Cost/Month: 9458 TND ( 273,005,170.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 9458 TND ( 273,005,170.00 LBP )
● Cost/Day: 9458 TND ( 273,005,170.00 LBP )
● Cost/Month: 9458 TND ( 273,005,170.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 5434 AED ( 131,290,874.00 LBP )
● Cost/Day: 5434 AED ( 131,290,874.00 LBP )
● Cost/Month: 5434 AED ( 131,290,874.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Day: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Month: 1063,35 CHF ( 109,935,460.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Day: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Month: 1063,35 CHF ( 109,935,460.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Day: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Month: 1063,35 CHF ( 109,935,460.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Day: 1063,35 CHF ( 109,935,460.00 LBP )
● Cost/Month: 1063,35 CHF ( 109,935,460.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Day: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Month: 1102,23 EUR ( 106,757,352.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Day: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Month: 1102,23 EUR ( 106,757,352.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Day: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Month: 1102,23 EUR ( 106,757,352.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Day: 1102,23 EUR ( 106,757,352.00 LBP )
● Cost/Month: 1102,23 EUR ( 106,757,352.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Day: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Month: 4246 QAR ( 104,273,268.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Day: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Month: 4246 QAR ( 104,273,268.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Day: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Month: 4246 QAR ( 104,273,268.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Day: 4246 QAR ( 104,273,268.00 LBP )
● Cost/Month: 4246 QAR ( 104,273,268.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Day: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Month: 1073,01 EUR ( 103,947,948.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Day: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Month: 1073,01 EUR ( 103,947,948.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Day: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Month: 1073,01 EUR ( 103,947,948.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Day: 1073,01 EUR ( 103,947,948.00 LBP )
● Cost/Month: 1073,01 EUR ( 103,947,948.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Day: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Month: 1071,43 EUR ( 103,754,196.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Day: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Month: 1071,43 EUR ( 103,754,196.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Day: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Month: 1071,43 EUR ( 103,754,196.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Day: 1071,43 EUR ( 103,754,196.00 LBP )
● Cost/Month: 1071,43 EUR ( 103,754,196.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Day: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Month: 446,99 OMR ( 102,907,364.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Day: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Month: 446,99 OMR ( 102,907,364.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Day: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Month: 446,99 OMR ( 102,907,364.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Day: 446,99 OMR ( 102,907,364.00 LBP )
● Cost/Month: 446,99 OMR ( 102,907,364.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Day: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Month: 158545 ISK ( 102,261,525.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Day: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Month: 158545 ISK ( 102,261,525.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Day: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Month: 158545 ISK ( 102,261,525.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Day: 158545 ISK ( 102,261,525.00 LBP )
● Cost/Month: 158545 ISK ( 102,261,525.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Day: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Month: 348,3 KWD ( 102,166,188.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Day: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Month: 348,3 KWD ( 102,166,188.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Day: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Month: 348,3 KWD ( 102,166,188.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Day: 348,3 KWD ( 102,166,188.00 LBP )
● Cost/Month: 348,3 KWD ( 102,166,188.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Day: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Month: 7621,75 DKK ( 98,890,096.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Day: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Month: 7621,75 DKK ( 98,890,096.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Day: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Month: 7621,75 DKK ( 98,890,096.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Day: 7621,75 DKK ( 98,890,096.00 LBP )
● Cost/Month: 7621,75 DKK ( 98,890,096.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 816 GBP ( 92,737,584.00 LBP )
● Cost/Day: 816 GBP ( 92,737,584.00 LBP )
● Cost/Month: 816 GBP ( 92,737,584.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 816 GBP ( 92,737,584.00 LBP )
● Cost/Day: 816 GBP ( 92,737,584.00 LBP )
● Cost/Month: 816 GBP ( 92,737,584.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 816 GBP ( 92,737,584.00 LBP )
● Cost/Day: 816 GBP ( 92,737,584.00 LBP )
● Cost/Month: 816 GBP ( 92,737,584.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 816 GBP ( 92,737,584.00 LBP )
● Cost/Day: 816 GBP ( 92,737,584.00 LBP )
● Cost/Month: 816 GBP ( 92,737,584.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Day: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Month: 732,62 JOD ( 91,661,772.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Day: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Month: 732,62 JOD ( 91,661,772.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Day: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Month: 732,62 JOD ( 91,661,772.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Day: 732,62 JOD ( 91,661,772.00 LBP )
● Cost/Month: 732,62 JOD ( 91,661,772.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Day: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Month: 377,33 BHD ( 89,625,718.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Day: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Month: 377,33 BHD ( 89,625,718.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Day: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Month: 377,33 BHD ( 89,625,718.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Day: 377,33 BHD ( 89,625,718.00 LBP )
● Cost/Month: 377,33 BHD ( 89,625,718.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Day: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Month: 3633,1 SAR ( 85,884,120.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Day: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Month: 3633,1 SAR ( 85,884,120.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Day: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Month: 3633,1 SAR ( 85,884,120.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Day: 3633,1 SAR ( 85,884,120.00 LBP )
● Cost/Month: 3633,1 SAR ( 85,884,120.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Day: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Month: 872,09 EUR ( 84,475,872.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Day: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Month: 872,09 EUR ( 84,475,872.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Day: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Month: 872,09 EUR ( 84,475,872.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Day: 872,09 EUR ( 84,475,872.00 LBP )
● Cost/Month: 872,09 EUR ( 84,475,872.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Day: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Month: 830,71 EUR ( 80,407,080.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Day: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Month: 830,71 EUR ( 80,407,080.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Day: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Month: 830,71 EUR ( 80,407,080.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Day: 830,71 EUR ( 80,407,080.00 LBP )
● Cost/Month: 830,71 EUR ( 80,407,080.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Day: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Month: 829,83 EUR ( 80,310,204.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Day: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Month: 829,83 EUR ( 80,310,204.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Day: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Month: 829,83 EUR ( 80,310,204.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Day: 829,83 EUR ( 80,310,204.00 LBP )
● Cost/Month: 829,83 EUR ( 80,310,204.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Day: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Month: 9276,8 NOK ( 75,172,704.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Day: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Month: 9276,8 NOK ( 75,172,704.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Day: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Month: 9276,8 NOK ( 75,172,704.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Day: 9276,8 NOK ( 75,172,704.00 LBP )
● Cost/Month: 9276,8 NOK ( 75,172,704.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Day: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Month: 716,36 EUR ( 69,363,216.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Day: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Month: 716,36 EUR ( 69,363,216.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Day: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Month: 716,36 EUR ( 69,363,216.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Day: 716,36 EUR ( 69,363,216.00 LBP )
● Cost/Month: 716,36 EUR ( 69,363,216.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Day: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Month: 18081,43 CZK ( 69,051,339.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Day: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Month: 18081,43 CZK ( 69,051,339.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Day: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Month: 18081,43 CZK ( 69,051,339.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Day: 18081,43 CZK ( 69,051,339.00 LBP )
● Cost/Month: 18081,43 CZK ( 69,051,339.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Day: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Month: 65161855,27 LBP ( 65,161,855.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Day: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Month: 65161855,27 LBP ( 65,161,855.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Day: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Month: 65161855,27 LBP ( 65,161,855.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Day: 65161855,27 LBP ( 65,161,855.00 LBP )
● Cost/Month: 65161855,27 LBP ( 65,161,855.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Day: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Month: 671,46 EUR ( 65,003,796.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Day: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Month: 671,46 EUR ( 65,003,796.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Day: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Month: 671,46 EUR ( 65,003,796.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Day: 671,46 EUR ( 65,003,796.00 LBP )
● Cost/Month: 671,46 EUR ( 65,003,796.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Day: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Month: 641,09 EUR ( 62,097,516.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Day: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Month: 641,09 EUR ( 62,097,516.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Day: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Month: 641,09 EUR ( 62,097,516.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Day: 641,09 EUR ( 62,097,516.00 LBP )
● Cost/Month: 641,09 EUR ( 62,097,516.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Day: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Month: 2828,43 TRY ( 7,579,040.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Day: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Month: 2828,43 TRY ( 7,579,040.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Day: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Month: 2828,43 TRY ( 7,579,040.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Day: 2828,43 TRY ( 7,579,040.00 LBP )
● Cost/Month: 2828,43 TRY ( 7,579,040.00 LBP )
Diabetic macular oedema :
● Cost/Unit: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Day: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Month: 61418,55 ARS ( 5,896,128.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Day: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Month: 61418,55 ARS ( 5,896,128.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Day: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Month: 61418,55 ARS ( 5,896,128.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Day: 61418,55 ARS ( 5,896,128.00 LBP )
● Cost/Month: 61418,55 ARS ( 5,896,128.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info